CMI_LatestReportOrientedBlogs

Hashimoto’s Thyroiditis Drug Market Hashimoto's thyroiditis, also known as chronic lymphocytic thyroiditis, is the most common cause of hypothyroidism. It is an autoimmune disease where the immune system attacks the thyroid gland, leading to inflammation and damage over time. Symptoms include fatigue, weight gain, feeling cold, constipation, depression, muscle and joint pain. Drugs used for treatment include levothyroxine for lifelong hormone replacement and corticosteroids in certain cases to reduce inflammation. The global Hashimoto’s thyroiditis drug market is estimated to be valued at US$ 2.18 billion in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period from 2024 to 2031. Key Takeaways Key players operating in the Hashimoto’s thyroiditis drug are AbbVie Inc., Merck & Co., Allergan., Amneal Pharmaceuticals., Lannett Company, Mylan Pharmaceuticals, Pfizer, Akorn Pharmaceuticals, Acella Pharmaceuticals, Jerome Stevens Pharmaceuticals and Other Promine

Medical Probiotics Market The Medical Probiotics Market consists of solutions containing good bacteria to maintain a healthy gut and overall wellness. Probiotic supplements aid in digestion, boost immunity and lower risks of illness by regulating gut microbiota. With increasing health consciousness, probiotic yogurt, capsules and other products are gaining widespread acceptance. The global Medical Probiotics Market is estimated to be valued at US$ 4.43 Billion in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Emerging evidence supporting the role of probiotics in preventing numerous diseases has accelerated Medical Probiotics Market Demand in recent years. Studies indicating probiotic benefits in reducing risks of chronic conditions like diabetes, obesity, cardiovascular disease and certain cancers have raised awareness. Their use as a cost-effective and natu

Neutralizing Antibody Market Neutralizing antibodies are antibodies that are directed against specific antigens or pathogen epitopes and can neutralize pathogenic effects of macromolecules like proteins on cells or in extracellular space. Neutralizing antibodies help treat diseases like cancer, HIV, and infectious diseases by blocking the activity of targeted pathogens or antigens. The global Neutralizing Antibody Market is estimated to be valued at US$ 1.87 Bn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing prevalence of cancer and viral infections is the major factor augmenting the growth of the Neutralizing Antibody Market. As per WHO, cancer accounted for nearly 10 million deaths in 2020. Strong R&D efforts by key players to develop monoclonal neutralizing antibodies for treatment of various types of cancer is creating high demand for n

Genomic Cancer Testing Market Genomic cancer testing helps in determining cancer type and its driver genes for effective treatment of cancer. Such testing provide accurate diagnosis and assist oncologists in personalized treatment planning. The genomic profiling helps analyze cancer cells at molecular level and recommend targeted therapy. Advancements in next-generation sequencing technologies have enabled high-throughput and cost-effective cancer testing. The global Genomic Cancer Testing Market is estimated to be valued at US$ 13.67 billion in 2024 and is expected to exhibit a CAGR of 7.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The innovation in cancer testing techniques has accelerated the growth of Genomic Cancer Testing Market. Next generation sequencing techniques such as whole genome sequencing and whole exome sequencing help analyze multiple genes simultaneously and provide comprehensive ge

Major Depressive Disorder Treatment Market Major Depressive Disorder (MDD), also known as clinical depression, is a common and serious mental illness that negatively affects mood, thoughts, behavior, feelings and physical health. It is estimated that more than 264 million people suffer from depression globally. The rise in prevalence of depressive disorders can mainly be attributed to factors such as stressful lifestyle, substance abuse, genetics and medical illnesses. Depressive disorder treatments include antidepressants, psychotherapy and counseling that help in managing the symptoms effectively. The global Major Depressive Disorder Treatment Market is estimated to be valued at US$ 13.63 Bn in 2024 and is expected to exhibit a CAGR of 24.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends fueling the growth of major depressive disorder treatment market is rising adoption of ele

  Lidocaine Patches Market Lidocaine patches provide pain relief to patients suffering from post-herpetic neuralgia (PHN), also known as shingles pain, and other neuropathic pain conditions. Lidocaine patches work by delivering numbing agent lidocaine through the skin directly to the skin and nerves where it is needed. This reduces pain signals from being sent to the brain without circulating through the bloodstream and causing systemic side effects. The global lidocaine patches market is estimated to be valued at US$ 6.47 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: Increased research collaborations between market players: Lidocaine patches market has witnessed increased focus on research collaborations and partnerships between market players. For instance, in 2021, Durect Corporation and CASI Pharmaceuticals, Inc. announced a licensing agreement

Opioid Use Disorder Market Opioid Use Disorder affects millions of lives worldwide annually. Opioids are drugs that provide pain relief but also produce feelings of euphoria and a relaxation of the body. Due to their addictive properties, continuous use of opioids can lead to developing Opioid Use Disorder characterized by strong cravings and compulsive use. Buprenorphine and methadone are effective therapies for treating Opioid Use Disorder by reducing withdrawal symptoms and relieving drug cravings without producing pleasurable effects. The global Opioid Use Disorder Market is estimated to be valued at US$ 3236.55 Mn in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing prevalence of Opioid Use Disorder worldwide has accelerated the growth of the Opioid Use Disorder Market. As per estimates, around 35 million people suffer from Opioid Use Dis

  Lyme Disease Treatment Market Lyme disease treatment is used for eradicating the tick-borne bacterial infection known as Lyme disease caused by the Borrelia burgdorferi pathogen. Lyme disease treatment primarily consists of antibiotics such as doxycycline, amoxicillin and cefuroxime that are used for treating early-stage Lyme disease. However, late-stage Lyme disease requires intravenous treatment through ceftriaxone or penicillin G. The need for Lyme disease treatment is growing globally as Lyme disease has emerged as one the fastest spreading vector-borne illnesses reported in the United States and Europe. The global Lyme Disease Treatment Market is estimated to be valued at US$ 1.56 Bn in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: There is high growth opportunity for improved diagnostic methods in the Lyme disease treatment market. Currently, di

Personalized Genomics Market Personalized genomics involves testing and evaluating of an individual's DNA and RNA molecular patterns to enable personalized healthcare. Personalized genomics helps in better understanding of an individual's genetics and risks for certain diseases. It also aids in analyzing nutrition requirements and recommending personalized diet plans based on one's genetic makeup. There is growing interest in nutrigenomics field which studies the interaction between diet and genetics. The global personalized genomics market is estimated to be valued at US$ 9.14 billion in 2023 and is expected to exhibit a CAGR of 0.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Growing Interest in Nutrigenomics The rising interest in understanding the interaction between diet and genetics is opening new growth opportunities in the field of nutrigenomics. Personalized genomics helps i

  PARP Inhibitor Market PARP inhibitors are therapeutics that inhibit the activity of poly ADP-ribose polymerase (PARP) enzymes involved in DNA repair. They are used for cancer treatment in combination with chemotherapy or radiation therapy. PARP inhibitors enhance the effects of DNA-damaging cancer therapies and prevent cancer cells from repairing damaged DNA. The global PARP Inhibitor Market is estimated to be valued at US$ 6.13 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The growing prevalence of cancer presents a major market opportunity for PARP inhibitors. Cancer is one of the leading causes of death worldwide and the number of new cases is increasing every year. According to WHO, cancer burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. PARP inhibitors have shown promising results in comb

Ophthalmic Drugs Market Ophthalmic drugs are medical drugs used for the treatment of various eye diseases and disorders. Some key ophthalmic drugs include anti-glaucoma drugs, dry eye medication, anti-infective drugs, anti-allergic drugs, non-steroidal anti-inflammatory drugs, and others. These drugs are used for treating various eye conditions like glaucoma, conjunctivitis, uveitis, dry eyes, infection, allergy, inflammation and other retinal diseases. The need for ophthalmic drugs is growing owing to the rising prevalence of eye diseases globally. The Global Ophthalmic Drugs Market is estimated to be valued at US$ 48.19 Bn in 2023 and is expected to exhibit a CAGR of 8.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The growing geriatric population remains one of the major opportunities for the ophthalmic drugs market. Age is one of the major risk factors for various ocular diseases like age-re

Pediatric Nutrition Market The pediatric nutrition market consists of specially formulated food and beverages for infants and toddlers. These products aim to provide balanced nutrition to support growth and development. They are enriched with vital nutrients like proteins, vitamins, minerals, and prevent nutritional deficiencies. The rising number of working mothers and busy lifestyles have increased the demand for convenient and healthy pediatic nutrition options like milk formulas, baby food, nutritional supplements, and functional drinks. The global pediatric nutrition market is estimated to be valued at US$ 14.22 Mn in 2023 and is expected to exhibit a CAGR of 4.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Growing health awareness among parents regarding balanced diets for their children is expected to drive the pediatric nutrition market. Parents are increasingly conscious about the food t

Primary Sclerosing Cholangitis Market Primary Sclerosing Cholangitis (PSC) is a chronic and progressive cholestatic liver disease characterized by inflammation and fibrosis of the bile ducts that can ultimately lead to cirrhosis and death from complications of end-stage liver disease. PSC can occur alone or may be associated with inflammatory bowel disease, mainly ulcerative colitis. The main product types associated with PSC are magnetic resonance cholangiopancreatography, endoscopic retrograde cholangiopancreatography, percutaneous transhepatic cholangioscopy and liver biopsy. These products play an important role in accurate diagnosis of PSC in early stages. The global Primary Sclerosing Cholangitis Market is estimated to be valued at US$ 1.98 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Early diagnosis of PSC can help doctors to closely mon

Visual Impairment Market Visual Impairment is on the rise globally due to increasing cases of diabetes, eye disorders, and aging population. Visual impairment products like Braille displays, screen magnification software, optical and non-optical aids are used to help people with visual disabilities carry out daily tasks and live independently. The global visual impairment market provides assistive technologies and rehabilitation services for low vision and blind individuals. The global visual impairment market is estimated to be valued at US$ 5511.15 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The rising geriatric population suffering from age-related visual impairment presents a significant market opportunity. As per the WHO, the number of people aged over 60 years is expected to double from 12% to 22% between 2015 and 2050 globally. Age-relat